Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Scher

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Behring Institute Mitteilungen|August 1, 1988
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropeniaJ L Gabrilove, A Jakubowski, H Scher, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?C N Sternberg, D Raghaven, Y Ohi, et al.
The Journal of Clinical Investigation|October 1, 1988
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urotheliumJ L Gabrilove, A Jakubowski, K Fain, et al.
Oncology (Williston Park, N.Y.)|August 12, 1998
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer NetworkH Scher, R Bahnson, S Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumorsG J Bosl, N L Geller, D Bajorin, et al.
Cancer Research|July 1, 1983
Multivariate analysis of prognostic variables in patients with metastatic testicular cancerG J Bosl, N L Geller, C Cirrincione, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|January 15, 2002
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correctionA Turlakow, S M Larson, F Coakley, et al.
Histology and Histopathology|May 16, 2000
Expression of c-kit and kit-ligand in benign and malignant prostatic tissuesR Simak, P Capodieci, D W Cohen, et al.
Cancer Research|March 27, 1998
Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formationR L Wu, I Osman, X R Wu, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Behring Institute Mitteilungen|August 1, 1988
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropeniaJ L Gabrilove, A Jakubowski, H Scher, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?C N Sternberg, D Raghaven, Y Ohi, et al.
The Journal of Clinical Investigation|October 1, 1988
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urotheliumJ L Gabrilove, A Jakubowski, K Fain, et al.
Oncology (Williston Park, N.Y.)|August 12, 1998
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer NetworkH Scher, R Bahnson, S Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumorsG J Bosl, N L Geller, D Bajorin, et al.
Cancer Research|July 1, 1983
Multivariate analysis of prognostic variables in patients with metastatic testicular cancerG J Bosl, N L Geller, C Cirrincione, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|January 15, 2002
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correctionA Turlakow, S M Larson, F Coakley, et al.
Histology and Histopathology|May 16, 2000
Expression of c-kit and kit-ligand in benign and malignant prostatic tissuesR Simak, P Capodieci, D W Cohen, et al.
Cancer Research|March 27, 1998
Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formationR L Wu, I Osman, X R Wu, et al.
Pageof 8